首页> 美国卫生研究院文献>Frontiers in Pharmacology >Interference With Coagulation Cascade as a Novel Approach to Counteract Cisplatin-Induced Acute Tubular Necrosis; an Experimental Study in Rats
【2h】

Interference With Coagulation Cascade as a Novel Approach to Counteract Cisplatin-Induced Acute Tubular Necrosis; an Experimental Study in Rats

机译:干扰凝血级联作为抗顺铂诱导的急性肾小管坏死的新方法;大鼠实验研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Coagulation system activation plays an important role in the pathophysiology of different diseases. In spite of massive research regarding cisplatin-induced nephrotoxicity, the role of coagulation cascade in such toxicity is still questionable. Here, we aim to investigate the role of activation of coagulation system in the initiation of cisplatin-induced acute renal tubular necrosis. Moreover, the role of the anticoagulant rivaroxaban against such toxicity was investigated. Briefly, animals were classified into seven groups, eight rats each. Group 1 served as normal control group, groups (2–7) received i.p. single doses of cisplatin (6 mg/kg b.w), groups (6–7) were treated with rivaroxaban (5 and 7 mg/kg b.w, p.o., respectively) 7 days before cisplatin injection and completed for 4 days. Animals in groups (2, 3, and 4) were sacrificed after 1, 2 and 3 days of cisplatin injection, respectively, while groups (1, 5, 6, and 7) were sacrificed after 4 days of cisplatin injection. Serum cystatin-c, urea, creatinine and γ-glutamyl transferase, urinary Lipocaline-2, and KIM-1 protein densities, as well as glomerular filtration rate (GFR) were assessed. Immunofluorescence examination of glomeruli fibrin and tissue factor (TF) was also performed coupled with a histopathological study. Cisplatin administration increased expression of fibrin and TF starting 24 h of cisplatin injection even before renal failure markers elevated. Leukocytosis, thrombocytopenia, and increased prothrombin time were also observed. Cisplatin also induced tubular damage evidenced by increased serum cystatin-c, urea, and creatinine with significant decrease in GFR and Gamma glutamyl transferase (GGT) activity. Rivaroxaban significantly decreased elevation of fibrin and TF with significant reduction in serum creatinine, BUN and cystatin-c levels. Rivaroxaban also significantly improved hematological markers and histological features as well. This study showed that activation of coagulation system plays an important role in the pathophysiology of cisplatin-induced acute renal tubular damage. Interference with coagulation cascade may be a promising nephroprotective strategy against chemical nephrotoxicity.
机译:凝血系统的激活在不同疾病的病理生理中起着重要作用。尽管对顺铂引起的肾毒性进行了大量研究,但是凝血级联在这种毒性中的作用仍然值得怀疑。在这里,我们旨在研究凝血系统的激活在顺铂诱导的急性肾小管坏死中的作用。此外,研究了抗凝血剂利伐沙班对这种毒性的作用。简而言之,将动物分为七组,每组八只大鼠。第1组作为正常对照组,第(2-7)组接受腹腔注射。单剂量顺铂(6 mg / kg b.w),组(6-7)在注射顺铂前7天用利伐沙班治疗(分别为p.o和5 mg / kg b.w),并完成4天。分别在第1、2和3天的顺铂注射后处死组(2、3和4)的动物,而在第4天的顺铂注射后处死组(1、5、6和7)。评估血清半胱氨酸蛋白酶抑制剂c,尿素,肌酐和γ-谷氨酰转移酶,尿液Lipocaline-2和KIM-1蛋白的密度以及肾小球滤过率(GFR)。还结合组织病理学研究进行了肾小球纤维蛋白和组织因子(TF)的免疫荧光检查。甚至在肾衰竭标志物升高之前,顺铂给药也可在顺铂注射后24小时开始增加纤维蛋白和TF的表达。还观察到白细胞增多,血小板减少和凝血酶原时间增加。顺铂还诱导肾小管损伤,其表现为血清胱抑素-c,尿素和肌酐升高,而GFR和Gamma谷氨酰转移酶(GGT)活性显着降低。利伐沙班显着降低了血纤蛋白和TF的升高,同时血清肌酐,BUN和胱抑素-c水平显着降低。利伐沙班还显着改善了血液学标志物和组织学特征。这项研究表明,凝血系统的激活在顺铂诱导的急性肾小管损伤的病理生理中起着重要作用。干扰凝血级联反应可能是针对化学肾毒性的一种有前景的肾保护策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号